| pubmed-article:402106 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:402106 | lifeskim:mentions | umls-concept:C0025159 | lld:lifeskim |
| pubmed-article:402106 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
| pubmed-article:402106 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
| pubmed-article:402106 | lifeskim:mentions | umls-concept:C0332120 | lld:lifeskim |
| pubmed-article:402106 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:402106 | pubmed:dateCreated | 1977-3-15 | lld:pubmed |
| pubmed-article:402106 | pubmed:abstractText | Exposure of growing cultures of Bacillus megaterium C4A(-) to ethidium bromide or an elevated growth temperature was found to eliminate megacin C production. Ethidium bromide resulted in a cure rate of up to 13%. Growth at 43 degrees C gave a cure rate of up to 99%. Megacin C production was lost spontaneously at a rate of 4% or less. There was a greater rate of spontaneous loss of megacin Cx production by B. megaterium 337, up to 14%. Growth at 43 degrees C resulted in a cure rate of up to 24% in this organism. Reversion to the Meg(+) state by cured clones has never been demonstrated. These observations support the hypothesis that production of megacins C and Cx is plasmid mediated. Meg(-) clones adsorbed more megacin than either parent strain and were more susceptible to megacin action. | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:language | eng | lld:pubmed |
| pubmed-article:402106 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:402106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:402106 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:402106 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:402106 | pubmed:issn | 0066-4804 | lld:pubmed |
| pubmed-article:402106 | pubmed:author | pubmed-author:DonoghueH DHD | lld:pubmed |
| pubmed-article:402106 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:402106 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:402106 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:402106 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:402106 | pubmed:pagination | 34-7 | lld:pubmed |
| pubmed-article:402106 | pubmed:dateRevised | 2010-9-2 | lld:pubmed |
| pubmed-article:402106 | pubmed:meshHeading | pubmed-meshheading:402106-T... | lld:pubmed |
| pubmed-article:402106 | pubmed:meshHeading | pubmed-meshheading:402106-B... | lld:pubmed |
| pubmed-article:402106 | pubmed:meshHeading | pubmed-meshheading:402106-S... | lld:pubmed |
| pubmed-article:402106 | pubmed:meshHeading | pubmed-meshheading:402106-B... | lld:pubmed |
| pubmed-article:402106 | pubmed:meshHeading | pubmed-meshheading:402106-P... | lld:pubmed |
| pubmed-article:402106 | pubmed:meshHeading | pubmed-meshheading:402106-E... | lld:pubmed |
| pubmed-article:402106 | pubmed:meshHeading | pubmed-meshheading:402106-M... | lld:pubmed |
| pubmed-article:402106 | pubmed:year | 1977 | lld:pubmed |
| pubmed-article:402106 | pubmed:articleTitle | Production of megacins C and Cx: presumptive evidence extrachromosomal control. | lld:pubmed |
| pubmed-article:402106 | pubmed:publicationType | Journal Article | lld:pubmed |
